Xla Wt + vangl2 MO has 9 phenotype(s)
Images Sources Experiment + Assay Phenotypes Human Diseases
fig.2.f, f^1

Ossipova O et al. (2015) 		Xla Wt + vangl2 MO

NF10.25 (immunohistochemistry)
Expression Phenotype
decreased amount myl2.L expression in blastopore lip
fig.2.b

Ossipova O et al. (2015) 		Xla Wt + vangl2 MO

NF10.25 (morphology)
Anatomical Phenotype
absent blastopore
fig.s4.a

Ossipova O et al. (2015) 		Xla Wt + vangl2 MO

NF10.25 (morphology)
Anatomical Phenotype
abnormal development of upper blastopore lip
fig.5..f

Ossipova O et al. (2015) 		Xla Wt + vangl2 MO

NF10.5 (morphology)
Expression Phenotype
mislocalised rab11a.L expression in bottle cell
fig.s2.g

Ossipova O et al. (2015) 		Xla Wt + vangl2 MO

NF11 (immunohistochemistry)
Expression Phenotype
decreased amount actl6a.S expression in blastopore
fig.1.e, f

Ossipova O et al. (2015) 		Xla Wt + vangl2 MO

NF11 (morphology)
Expression Phenotype
mislocalised vangl1.L expression in ectodermal cell
fig.5..h

Ossipova O et al. (2015) 		Xla Wt + vangl2 MO

NF11 (morphology)
Expression Phenotype
mislocalised rab11a.L expression in ectodermal cell
fig.s2.b

Ossipova O et al. (2015) 		Xla Wt + vangl2 MO

NF11 (morphology)
Anatomical Phenotype
abnormally delayed closure of blastopore
fig.s2.d

Ossipova O et al. (2015) 		Xla Wt + vangl2 MO

NF11 (morphology)
Anatomical Phenotype
abnormally delayed closure of blastopore